−0.035CAD
−3.81 MCAD
718.30 KCAD
93.02 M
About RAPID DOSE THERAPEUTICS CORP.
Sector
Industry
CEO
Mark Upsdell
Website
Headquarters
Burlington
Founded
2008
ISIN
CA75339A1012
FIGI
BBG00MTJ0588
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company, which engages in providing innovative, proprietary, and drug-delivery technologies designed to improve outcomes and quality of lives. It owns a proprietary oral fast dissolving drug delivery system, QuickStrip. It operates through the following business segments: Health and Wellness, White Label, and MSSA. The Health and Wellness segment includes nutraceuticals and infused soaps. The White Label segment refers to the selling of oral thin film strips containing active ingredients under cannabis licensing. The MSSA segment is involved in MSSA contracts, and licensing and other related services. The company was founded on February 27, 2008 and is headquartered in Burlington, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DOSE is 0.205 CAD — it has increased by 2.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange RAPID DOSE THERAPEUTICS CORP. stocks are traded under the ticker DOSE.
RAPID DOSE THERAPEUTICS CORP. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
DOSE stock is 10.26% volatile and has beta coefficient of −0.49. Check out the list of the most volatile stocks — is RAPID DOSE THERAPEUTICS CORP. there?
Yes, you can track RAPID DOSE THERAPEUTICS CORP. financials in yearly and quarterly reports right on TradingView.
DOSE stock has fallen by 6.82% compared to the previous week, the month change is a 20.59% rise, over the last year RAPID DOSE THERAPEUTICS CORP. has showed a 156.25% increase.
DOSE net income for the last quarter is −981.08 K CAD, while the quarter before that showed −730.69 K CAD of net income which accounts for −34.27% change. Track more RAPID DOSE THERAPEUTICS CORP. financial stats to get the full picture.
Today RAPID DOSE THERAPEUTICS CORP. has the market capitalization of 20.99 M, it has increased by 10.00% over the last week.
No, DOSE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DOSE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RAPID DOSE THERAPEUTICS CORP. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RAPID DOSE THERAPEUTICS CORP. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RAPID DOSE THERAPEUTICS CORP. stock shows the neutral signal. See more of RAPID DOSE THERAPEUTICS CORP. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RAPID DOSE THERAPEUTICS CORP. EBITDA is −2.34 M CAD, and current EBITDA margin is −406.01%. See more stats in RAPID DOSE THERAPEUTICS CORP. financial statements.